DiMe Research Committee working group reviews methods and definitions by which adherence has been captured and reported using BioMets in order to identify gaps and provide recommendations to the field.
July 28, 2022
DiMe Research Committee working group explores the potential, risks, and key considerations for organizations to consider when using a “BYOD” approach in clinical research
July 28, 2022
In partnership with IMPACT member Wellinks, DiMe leadership discuss how virtual-first care can improve patient experience and engagement across the care journey and optimize handoffs between care settings
July 27, 2022
DiMe CEO, Jen Goldsack, describes the imperative for preparing for the use of sensor data at scale
July 26, 2022
The Digital Medicine Society and American Telemedicine Association have developed a new toolkit to support the integration of virtual and in-person healthcare.
June 28, 2022
A letter submitted on behalf of the Digital Medicine Society (DiMe) for consideration by the U.S. Food and Drug Administration (FDA) regarding Docket No. FDA-2021-D-0789 for “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry; Availability .”
DiMe, Johns Hopkins, and BlueHealth Intelligence publish one of the first studies probing telehealth outcomes during the pandemic.
April 27, 2022
DiMe leadership describe the opportunity of virtual-first care, or V1C, to increase the quality of healthcare and make it more patient-centric by letting patients combine in-person visits with virtual options such as video for seeing their care providers.
April 14, 2022
The FDA released a draft guidance regarding the use of digital health technologies in remote clinical investigation.
DiMe and German Federal Ministry of Health publish global priorities for innovation in real-world evidence generation to advance digital health applications
On behalf of the DiMe community, we submitted a response to the White House Office of Science and Technology Policy (OSTP) RFI highlighting the power of DiMe’s multi-stakeholder, interdisciplinary program delivery model to transform community health, individual wellness, and health equity. Connected community health requires meeting the needs of the community through services and improved knowledge for the community and those working with them.
February 23, 2022
DiMe and VA leadership defines characteristics of a value-chain approach to successful digital health innovation in practice
February 18, 2022
February 17, 2022
February 15, 2022
DiMe CEO, Jen Goldsack, discusses anticipated 2022 trends in digital health and the life sciences with PharmaPhorum’s Jonah Comstock
DiMe Program Lead, Smit Patel, joins Megan Coder, Walter Greenleaf, Basker Gummadi, Dominick Kennerson and Loreen Brown at DTx Global Virtual Summit to discuss: “Embracing Digital Therapeutics and the Progressive Future of Digital Health”
December 16, 2021